Edition:
India

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

24.21USD
15 Feb 2019
Change (% chg)

$0.63 (+2.67%)
Prev Close
$23.58
Open
$23.75
Day's High
$24.22
Day's Low
$23.15
Volume
255,145
Avg. Vol
217,779
52-wk High
$41.75
52-wk Low
$21.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.887
Jun '18 0.00 -0.908
Mar '18 0.00 -0.924
FY 2017 Dec '17 0.00 -0.281
Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 6 0.00 0.00 0.00 0.00
Quarter Ending Jun-19 6 0.00 0.00 0.00 0.00
Year Ending Dec-19 11 20.95 142.01 0.00 54.61
Earnings (per share)
Quarter Ending Mar-19 7 -0.89 -0.73 -0.97 -0.83
Quarter Ending Jun-19 7 -0.91 -0.73 -0.99 -0.84
Year Ending Dec-19 11 -3.42 -1.47 -4.14 -2.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.48 33.70
P/E High - Last 5 Yrs. -- 44.98 49.87
P/E Low - Last 5 Yrs. -- 23.63 24.25
Beta -- 0.90 0.90
Price to Sales (TTM) -- 4.12 6.29
Price to Book (MRQ) 5.40 5.10 5.26
Price to Tangible Book (MRQ) 5.41 5.85 6.77
Price to Cash Flow (TTM) -- 24.01 24.98
% Owned Institutions 85.47 0.90 1.69

Dividends

  Company industry sector
Dividend Yield -- 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.15 4.85
Payout Ratio(TTM) -- 43.91 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.31 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 4.07 5.84
Sales - 5 Yr. Growth Rate -- 10.91 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago -49.09 44.94 47.15
EPS (TTM) vs TTM 1 Yr. Ago -44.88 -- --
EPS - 5 Yr. Growth Rate -- 10.31 10.85
Capital Spending - 5 Yr. Growth Rate -- 15.88 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.25
Current Ratio (MRQ) 13.45 2.97 3.08
LT Debt to Equity (MRQ) 0.00 8.84 11.38
Total Debt to Equity (MRQ) 0.00 12.89 16.12
Interest Coverage (TTM) -- 33.79 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 53.68 53.81
Gross Margin - 5 Yr. Avg. -- 51.67 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.96 12.87
Operating Margin (TTM) -- 14.31 6.20
Operating Margin - 5 Yr. Avg. -- 14.24 8.31
Pre-Tax Margin (TTM) -- 14.85 7.16
Pre-Tax Margin - 5 Yr. Avg. -- 14.68 8.61
Net Profit Margin (TTM) -- 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) -- 23.02 22.91
Effective Tax Rate - 5 Yr. Avg. -- 23.16 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 957,645,487 842,398,385
Net Income/Employee (TTM) -1,529,406 113,564,537 99,842,801
Receivable Turnover (TTM) -- 5.71 5.71
Inventory Turnover (TTM) -- 2.61 3.47
Asset Turnover (TTM) 0.00 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.75 11.52 11.06
Return on Assets - 5 Yr. Avg. -- 12.92 12.20
Return on Investment (TTM) -50.47 14.95 14.45
Return on Investment - 5 Yr. Avg. -- 16.84 15.87
Return on Equity (TTM) -50.82 16.27 15.96
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.22 5.45 99 22
13 Week 22.10 16.15 99 39
26 Week 26.67 17.04 99 33
52 Week 53.60 30.19 99 9
YTD 24.01 8.91 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.39%
# of Holders: 187
Total Shares Held: 51,675,202
3 Mo. Net Change: 1,859,954
# New Positions: 26
# Closed Positions: 36
# Increased Positions: 94
# Reduced Positions: 84
# Net Buyers: 10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.